Meyka Pro banner
Nutriband Inc.

Nutriband Inc. Fundamental Analysis (NASDAQ: NTRBW)

NTRBW●NASDAQ
HealthcareBiotechnology
$0.55
$1.18(68.21%)
U.S. Market opens in 62h 11m

Nutriband Inc. Fundamental Analysis (NASDAQ: NTRBW)

Nutriband Inc. (NASDAQ: NTRBW) shows weak financial fundamentals with a PE ratio of -13.30, profit margin of -4.30%, and ROE of -1.09%. The company generates $0.0B in annual revenue with weak year-over-year growth of -4.83%.

Key Strengths

PEG Ratio-0.15
Current Ratio4.21

Areas of Concern

ROE-1.09%
Operating Margin-4.36%
Cash Position4.47%
We analyze NTRBW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -407.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-407.5/100

We analyze NTRBW's fundamental strength across five key dimensions:

Efficiency Score

Weak

NTRBW struggles to generate sufficient returns from assets.

ROA > 10%
-1.11%

Valuation Score

Excellent

NTRBW trades at attractive valuation levels.

PE < 25
-13.30
PEG Ratio < 2
-0.15

Growth Score

Weak

NTRBW faces weak or negative growth trends.

Revenue Growth > 5%
-4.83%
EPS Growth > 10%
-1.61%

Financial Health Score

Excellent

NTRBW maintains a strong and stable balance sheet.

Debt/Equity < 1
0.04
Current Ratio > 1
4.21

Profitability Score

Weak

NTRBW struggles to sustain strong margins.

ROE > 15%
-109.02%
Net Margin ≥ 15%
-4.30%
Positive Free Cash Flow
No

Key Financial Metrics

Is NTRBW Expensive or Cheap?

P/E Ratio

NTRBW trades at -13.30 times earnings. This suggests potential undervaluation.

-13.30

PEG Ratio

When adjusting for growth, NTRBW's PEG of -0.15 indicates potential undervaluation.

-0.15

Price to Book

The market values Nutriband Inc. at 17.36 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

17.36

EV/EBITDA

Enterprise value stands at -14.06 times EBITDA. This is generally considered low.

-14.06

How Well Does NTRBW Make Money?

Net Profit Margin

For every $100 in sales, Nutriband Inc. keeps $-4.30 as profit after all expenses.

-4.30%

Operating Margin

Core operations generate -4.36 in profit for every $100 in revenue, before interest and taxes.

-4.36%

ROE

Management delivers $-1.09 in profit for every $100 of shareholder equity.

-1.09%

ROA

Nutriband Inc. generates $-1.11 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.11%

Following the Money - Real Cash Generation

Operating Cash Flow

Nutriband Inc. generates limited operating cash flow of $-3.57M, signaling weaker underlying cash strength.

$-3.57M

Free Cash Flow

Nutriband Inc. generates weak or negative free cash flow of $-3.57M, restricting financial flexibility.

$-3.57M

FCF Per Share

Each share generates $-0.30 in free cash annually.

$-0.30

FCF Yield

NTRBW converts -4.03% of its market value into free cash.

-4.03%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-13.30

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.15

vs 25 benchmark

P/B Ratio

Price to book value ratio

17.36

vs 25 benchmark

P/S Ratio

Price to sales ratio

57.19

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.04

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.21

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.09

vs 25 benchmark

ROA

Return on assets percentage

-1.11

vs 25 benchmark

ROCE

Return on capital employed

-1.31

vs 25 benchmark

How NTRBW Stacks Against Its Sector Peers

MetricNTRBW ValueSector AveragePerformance
P/E Ratio-13.3029.79 Better (Cheaper)
ROE-109.02%576.00% Weak
Net Margin-430.43%28998.00% Weak
Debt/Equity0.040.52 Strong (Low Leverage)
Current Ratio4.215.81 Strong Liquidity
ROA-110.64%-30.00% (disorted) Weak

NTRBW outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Nutriband Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

24.82%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-48.12%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-899.71%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ